Table 3.
Study | Location | Input | Purpose | Output | Evaluation | Public availability |
---|---|---|---|---|---|---|
Afzal, 202029 | Multinational | MD, Mono, Ab, Lit | CDM, U | Inf, Ext | I, Quan | DA |
Bavani, 201630 | Australia | MD, Mono, Ab, Lit | CDM, U | Inf, Abs | I, Quan | DA |
Bhaskoro, 201731 | Indonesia | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | |
Bui, 201632 | USA | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Chiang, 201433 | Taiwan, China | MD, Mono, FT, Related | PHIS, G | Inf, Ext | I, Quan and Qual | DA |
Cohan, 201834 | USA | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Conroy, 201835 | USA | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Davoodijam, 202136 | Iran | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Deng, 202022 | China | SD, Mono, FT, Related | BR, U | Inf, Ext | I, Quan and Qual | DA |
Du, 202037 | China | SD, Mono, Ab, Lit | BR, G | Inf, Ext | I, Quan and Qual | DA |
Dudko, 201738 | Multinational | MD, Mono, FT, EHR | CDM, G | Inf and Ind, Abs | I, Quan and Qual | DA |
Gayathri, 201539 | India | SD, Mono, FT, Related | BR, G | Inf, Ext | I, Quan | DA |
Gayathri, 201526 | India | SD, Mono, FT, Related | BR, G | Inf, Ext | I, Quan | DA |
Gigioli, 201940 | USA | SD, Mono, Ab, Lit | BR, G | Inf, Abs | I, Quan and Qual | DA |
Goldstein, 201341 | Israel | MD, Mono, FT, EHR | CDM, G | Inf, Abs | I, Qual | DA |
Goldstein, 201542 | Israel | MD, Mono, FT, EHR | CDM, G | Inf, Abs | I, Qual | DA |
Goldstein, 201643 | Israel | MD, Mono, FT, EHR | CDM, G | Inf, Abs | I and E, Quan | |
Goldstein, 201744 | Israel | MD, Mono, FT, EHR | CDM, G | Inf, Abs | I and E, Quan and Qual | |
Goodwin, 202021 | USA | SD, Mono, FT, Lit | PHIS, U | Inf, Abs | I, Quan | DA, CA |
Gulden, 201945 | Germany | SD, Mono, FT, Related | BR, G | Inf, Ext | I, Quan, Qual | DA |
Guo, 201346 | Multinational | SD, Mono, FT, Lit | BR, U | Inf, Ext | I and E, Quan and Qual | DA, CA |
Kim, 201847 | South Korea | MD, Mono, FT, Lit | PHIS and CDM, U | Inf, Ext | I, Quan | DA |
Lee, 202048 | USA | SD, Mono, FT, Lit | CDM, U | Inf and Ind, Ext | I, Quan and Qual | DA, CA |
Liu, 201949 | China | MD, Mono, FT, Related | PHIS, G | Inf, Ext | I, Quan and Qual | DA |
Lloret, 201350 | Spain | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan and Qual | DA |
Malakasiotis, 201551 | Greece | MD, Mono, Ab, Lit | BR, U | Inf, Ext | I, Quan | DA |
Mitrović, 201552 | Switzerland | SD, Mono, Ab and FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Moen, 201653 | Multinational | MD, Mono, FT, EHR | CDM, G | Inf, Ext | I, Quan | |
Moradi, 201754 | Iran | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Moradi, 201855 | Iran | SD and MD, Mono, Ab and FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Moradi, 201856 | Iran | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Moradi, 201857 | Iran | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Moradi, 201958 | Austria | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA, CA |
Moradi, 202028 | Multinational | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan and Qual | DA, CA |
NasrAzadani, 201859 | Iran | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
NasrAzadani, 201860 | Iran | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Nguyen, 201361 | Multinational | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Parveen, 201562 | Germany | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Parveen, 201563 | Germany | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
PolepalliRamesh, 201564 | USA | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Puyana, 201365 | Colombia | MD, Mono, FT, EHR | CDM, U | Inf, Ext | I, Quan and Qual | |
Rouane, 201966 | Algeria | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Rouane, 201919 | Algeria | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Rouane, 202067 | Algeria | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Sarker, 201368 | Australia | SD, Mono, Ab, Lit | CDM, U | Inf, Ext | I, Quan | DA |
Sarker, 201669 | Australia | SD, Mono, Ab, Lit | CDM, U | Inf, Ext | I, Quan and Qual | DA |
Scott, 201324 | UK | MD, Mono, FT, EHR | CDM, U | Inf, Ext | E, Quan and Qual | |
Shree, 202017 | India | MD, Mono, FT, EHR | BR and CDM, G | Inf, Ext | I and E, Quan | |
Sibunruang, 201870 | Thailand | SD, Mono, Ab, Lit | CDM, G | Inf, Ext | I, Quan | DA |
Siranjeevi, 202071 | India | SD, Mono, FT, Lit | BR, G | Inf, Ext | I, Quan | DA |
Song, 202023 | China | SD, Mono, Ab, Lit | BR, G | Inf, Abs | I, Quan | DA |
Sotudeh, 202072 | USA | SD, Mono, FT, EHR | CDM, G | Inf, Abs | I, Quan | DA |
Suominen, 201373 | Australia | MD, Mono, FT, EHR | CDM, G | Inf, Ext | E, Quan and Qual | |
Ting, 201374 | Multinational | SD, Mono, FT, Lit | CDM, G | Inf, Ext | E, Quan and Qual | DA |
Villa-Monte, 201975 | Multinational | SD, Mono, FT, Lit | BR, U | Inf, Ext | I, Quan | DA |
Villa-Monte, 202076 | Multinational | SD, Mono, FT, Lit | BR, U | Inf, Ext | I, Quan | DA |
Xu, 201677 | China | MD, Mono, Ab, Lit | PHIS, U | Inf, Ext | I, Quan | DA |
Yin, 201478 | Multinational | MD, Mono, FT, Related | PHIS, U | Inf, Ext | I, Quan and Qual | DA |
Abbreviations: Ab, abstract; Abs, abstractive; BR, to facilitate biomedical research; CA, code publicly available; CDM, to facilitate biomedical clinical decision-making; DA, data publicly available (including partial); E, extrinsic; EHR, electronic health record; Ext, extractive; FT, full text; G, generic; I, intrinsic; Ind, indicative; Inf, informative; Lit, Literature; MD, multiple documents; ML, multilingual; Mono, monolingual; PHIS, to facilitate patient health information seeking; Qual, qualitative evaluation; Quan, quantitative evaluation; SD, single document; U, user-oriented.